Abstract:e13512 Background: SLC35F2 is a member of solute carrier family 35 which encode nucleotide sugar transporters localizing in the Golgi apparatus and/or the endoplasmic reticulum, and transport nucleotide sugars that have pooled in the cytosol into the lumen of this organelle, where most of the glycoconjugate synthesis occurs. However, the SLC35F2 subfamily has not been completely characterized with regard to its biological activity. In this study, we tested the hypothesis that SLC35F2 influences the biological behavior of lung cancer cell line. We examined the effect of the inhibition of SLC35F2 expression on proliferation and invasion by establishing the SLC35F2 knockdown lung cancer cell line using lentivirus-mediated RNA interference (RNAi). METHODS The lentiviral vector of small interfering RNA targeting SLC35F2 was introduced into H1299 cells by liposome-mediated transfection. The expression of SLC35F2 protein was measured by Western blot. The proliferation of H1299 cells was determined by cell counting kit-8 (CCK-8) assay. The migration and invasion ability of H1299 cells was evaluated by Transwell migration and invasion assay. Cell cycle analysis was also performed by fluorescence-activated cell sorting (FACS). RESULTS SLC35F2 expression was markedly down-regulated in H1299 cell clone transfected with the lentiviral vector harboring small interfering RNA targeting SLC35F2. The proliferation of H1299 cells decreased significantly compared with untransfected H1299 cells. Transwell migration assay showed that less H1299 cells could move through the artificial basement membrane when compared with untransfected H1299 cells (38.3±5.7 vs 113.5±8.5, P <0.05). The cell cycle of H1299 cells was changed. Compared with untransfected H1299 cells, the percentage of H1299 cells in S and G2/M phase decreased significantly (S phase: F15.31%±3.04% vs 27.00%±5.41%, P >0.05; GG2/M phase: F3.02%±1.10% vs 10.47%±1.72%, P <0.05), whereas the percentage of H1299 cells in G0/G1 phase increased remarkably (81.67%±3.98% vs 62.53%±1.89%, P <0.05). CONCLUSIONS RNA interference-mediated down-regulation of SLC35F2 by lentiviral vector can attenuate the proliferation and migration of H1299 cells.

Construction and Identification of a Recombinant Lentiviral Vector of RNA Interference of Lung Cancer Related Gene SLC35F2

Construction of recombinant lentivirus vector containing retinoic acid-induced gene G and its effect on human lung cancer A549 cell line

Influence on the behavior of lung cancer H1299 cells by silencing SLC35F2 expression

Construction and Identification of Lentiviral Vector of Sirna Specific for CTGF

Construction and Identification of Lent Viral Vector of Sirna Specific for S100A6 Gene

Influences of Over-Expression of VEGF-C and Its Inhibition on Biological Characteristics of NCI-H446 Human Small-Cell Lung Cancer Cells

Silencing of SLC35F2 Gene Influences the Biologic Behavior of Human Lung Cancer Cell Line H1299.

Construction of FasL Sirna Expression Vector and Its Expression in Lung Cancer Cell Line A549

[Establishment of a Lung Adenocarcinoma Cell Line Stably Expressing Small Interfering RNA Targeting Hepatoma-Derived Growth Factor and Detection of Interference Effect].

Construction of RNAi lentiviral vector targeting IGF1R gene and its effect on proliferation, migration and invasion of hepatocellular carcinoma cells

Construction of Survivin Specific Small Interfering RNA Expression Vector,its Antiproliferative and Proapoptotic Effect on Lung Adenocarcinoma Cells

Construction of FAK Sirna Expressing Vector and the Inhibitory Effects on the Expression of FAK in Lung Cancer Cell

Construction of Sh-Rps6 Lentivirus Vectors and Its Effect on Proliferation in Lung Adenocarcinoma A549 Cell Lines

Lentivirus-Mediated Sirna Interference Targeting Sgo-1 Inhibits Human Nsclc Cell Growth

Construction of Sirna Lentiviral Expressing Vector Targeting Pleiotrophin Gene and Its Impact on Growth and Apoptosis in H446 Cells of Human Small Cell Lung Cancer

Construction and Identification of Lentiviral Vector-mediated RNA Interference of VEGF Gene

Lentivirus-mediated Stable Silencing of Nm23-H1 Gene in Lung Cancer Cells and the Influence on Biological Behavior

The Inhibitory Effect of Survivin Expression Vector of Leukemia Cell Line HL-60 by RNAi

Construction of a Lentiviral Vector for RNA Interference of PRL -3 Gene and Estab-Lishment of Monoclone of Stably Infected HepG2 Cell Lines

Construction and identification of lentiviral knockdown plasmid pLKO.1-hSRF

Construction of Livin isoform-specific siRNA expression vector and its stable expression in SPC-A1 cells